X4 Pharmaceuticals (XFOR) Change in Inventory (2024 - 2025)

X4 Pharmaceuticals (XFOR) reported Change in Inventory of $399000.0 for Q4 2025, up 7.26% on a YoY basis from $372000.0 in Q4 2024, and down 56.15% quarter-over-quarter from $910000.0 in Q3 2025.

X4 Pharmaceuticals (XFOR) Change in Inventory (2024 - 2025) Analysis & Trends

X4 Pharmaceuticals has reported Change in Inventory for 2 years, with the latest figure at $399000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory rose 7.26% year-over-year to $399000.0; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (down 41.0% YoY), and the FY2025 full-year result was $1.7 million, down 41.0% from the prior year.
  • Change in Inventory for Q4 2025 stood at $399000.0, down from $910000.0 in the prior quarter.
  • The five-year high for Change in Inventory was $1.6 million in Q3 2024, with the low at $81000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Inventory (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 51,468.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 97.70 Mn
9 Abivax 94.37 Bn 94.37 Bn - -
10 X4 Pharmaceuticals 156.06 Mn 156.06 Mn 2.20 Mn 399,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 399,000.00
Dec 31, 2025 399,000.00
Sep 30, 2025 910,000.00
Sep 30, 2025 910,000.00
Jun 30, 2025 81,000.00
Jun 30, 2025 81,000.00
Mar 31, 2025 272,000.00
Mar 31, 2025 272,000.00
Dec 31, 2024 372,000.00
Dec 31, 2024 372,000.00
Sep 30, 2024 1.61 Mn
Sep 30, 2024 1.61 Mn
Jun 30, 2024 831,000.00
Jun 30, 2024 831,000.00